Health Predictions
11 sourced future predictions currently published in the Health category. Every prediction rests on a source, a criterion and a probability.
- The First In Vivo CRISPR-Cas9 Gene Editing Therapy, Lonvoguran Ziclumeran (Lonvo-z), Is Expected To Receive US FDA Approval In 2027 For Hereditary Angioedema. 2027
- AI-driven Drug Discovery Platforms Are Expected To Bring Their First Commercial Products To Market. 2027
- Gene Therapies Are Expected To Gain Widespread Approval For Rare Diseases And Enter Clinical Use. 2027
- Personalized MRNA Cancer Vaccines Are Expected To Show Promising Phase 3 Trial Results. 2027
- Moderna And Merck's Personalized MRNA Neoantigen Cancer Vaccine Intismeran Autogene (V940/mRNA-4157) Is Expected To Receive Its First Regulatory Approval In 2028 As Adjuvant Treatment For High-risk Melanoma. 2028
- AI-assisted Diagnostic Systems Are Expected To Reach Clinician-level Accuracy In Radiology And Pathology. 2028
- Genomics-based Personalized Medicine Is Expected To Become Standard Of Care In Oncology. 2028
- 3D Bioprinters Are Expected To Enter Clinical Use For Organ Transplantation. 2028
- The Personalized MRNA Cancer Vaccine From Moderna And Merck (Intismeran Combined With Keytruda) Will Receive Its First Approval From A Major Regulator (FDA Or EMA). 2029
- The First Gene Therapy Developed With Base-editing Technology Will Receive Regulatory Approval For Sickle Cell Disease Or Beta Thalassemia. 2032
- AI-assisted Diagnostic Systems Reach Physician-level Performance Across All Medical Imaging 2035